Arkema SA

AKE: XPAR (FRA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
€375.00YkvthDtqwkvwz

Arkema Beats Consensus in Q4; 2022 Guidance in Line

No-moat Arkema reported fourth-quarter EBITDA of EUR 417 million, up 44% over 2020 and ahead of the company-compiled consensus. 2022 guidance was broadly in line with our estimate and consensus. Overall, it was another strong quarter for Arkema but overshadowed by the geopolitical news of the Russian invasion of Ukraine. Shares were down around 6% intraday, similar to its more cyclical industrial-focused peers. We don’t expect to make a material change to our EUR 95 fair value estimate.

Sponsor Center